A recent clinical trial has shown that using the “our Methods”significantly restores levels of cTnI and pro-BNP in sepsis patients, reduce levels of inflammatory factors such as IL-6 and IL-10, and improve heart function. The gene discussed is TNNI3; the disease is Sepsis.